| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Jan 25 | VYNE VYNE Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.77 | 730,000 | 2.02 mm | 730,000 |
| 31 Dec 24 | VYNE VYNE Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 3.35 | 24,536 | 82.20 k | 476,061 |
| 30 Nov 24 | VYNE VYNE Therapeutics | Common Stock | Grant | Acquire A | No | No | 2.1 | 3,901 | 8.19 k | 500,597 |
| 30 Sep 24 | VYNE VYNE Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 1.88 | 685 | 1.29 k | 496,696 |
| 1 Jul 24 | VYNE VYNE Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 1.92 | 935 | 1.80 k | 497,654 |
